Skip to main content
. 2023 Mar 29;24(7):6420. doi: 10.3390/ijms24076420

Figure 1.

Figure 1

PD-L1 knockout in MDA-MB-231 cell line using CRISPR/Cas9. (A) Western blot showing the level of PD-L1 in different breast cell lines. (BE) Western blot showing the level of PD-L1 in the pure clones of the control, PD-L1.1, PD-L1.2, and PD-L1.3. (F) Western blot showing PD-L1 level in the pool of the three selected pure clones from the control and each design of sgRNA targeting PD-L1.